Skip to main content
NIH funding notice RFA-HD-23-006

Integrative Research in Gynecologic Health (R01 Clinical Trial Optional)

Closed on April 18, 2022.

Posted
January 31, 2022
Close date
April 18, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,647,228 in first-year total cost, median $823,614.

Most frequent study sections

  1. Special Emphasis Panel[ZHD1 DSR-L (50)]2

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY1
  2. UNIVERSITY OF MICHIGAN AT ANN ARBOR1
Competing awards under RFA-HD-23-006 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Novel biomarkers and pathways of persistent endometriosis-associated pain across the life course1R01HD111242-01AS-SANIE, SAWSANTERRY, KATHRYN L.UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$828,480ZHD1
2023Role of senescent cells in uterine fibroid pathogenesis1R01HD111243-01BORAHAY, MOSTAFA A.ELISSEEFF, JENNIFER HSEGARS, JAMES H.JOHNS HOPKINS UNIVERSITY, MD$818,748ZHD1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.